Accuitis Overview
- Founded
-
2011
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
PE Growth
- Financing Rounds
-
4
Accuitis General Information
Description
Operator of a clinical-stage pharmaceutical company focused on the development of new drugs to address under-served disease states. The company specializes in developing and marketing drug therapies for the treatment of rosacea and other topical skin and eye diseases, providing patients with drugs for the treatment of rosacea.
Contact Information
Website
www.accuitis.com
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
- 1005 Alderman Drive
- Suite 104
- Alpharetta, GA 30024
- United States
+1 (678) 000-0000
Accuitis Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Accuitis Executive Team (5)
Accuitis Board Members (5)
| Name | Representing | Role | Since |
|---|---|---|---|
| 00000000 0000000 0 | Bio/Med Investor Network | Board Member | 000 0000 |
| 0000000 0000000 | Accuitis | Co-Founder, Chief Financial Officer & Board Member | 000 0000 |
| 0000000 000000 | Accuitis | Co-Founder, President Chief Executive Officer & Board Member | 000 0000 |
| 000000 000000 00.0 | Self | Board Member | 000 0000 |
Accuitis Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Accuitis Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|